Skip to Content

AMG 446 (Fenofibrate (Micronized) 200 mg)

Pill with imprint AMG 446 is Orange, Capsule-shape and has been identified as Fenofibrate (Micronized) 200 mg. It is supplied by Amerigen Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AMG 446

Fenofibrate (Micronized)

Imprint
AMG 446
Strength
200 mg
Color
Orange
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amerigen Pharmaceuticals Inc.
Manufacturer
Inventia Healthcare Private Limited
National Drug Code (NDC)
43975-0306
Inactive Ingredients
silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k30, corn starch, sodium lauryl sulfate, magnesium silicate, titanium dioxide, gelatin, shellac, propylene glycol, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.